Immediate Impact

21 standout
Sub-graph 1 of 11

Citing Papers

Myasthenia gravis: the changing treatment landscape in the era of molecular therapies
2024 Standout
Ravulizumab in Aquaporin‐4–Positive Neuromyelitis Optica Spectrum Disorder
2023 Standout
1 intermediate paper

Works of Sarah Abbes being referenced

Assessing complement blockade in patients with paroxysmal nocturnal hemoglobinuria receiving eculizumab
2014

Author Peers

Author Last Decade Papers Cites
Sarah Abbes 92 10 136 65 9 206
Marta Melgosa 57 26 122 98 14 249
Álvaro Urbano 131 4 74 20 9 231
Shizunori Ichida 58 24 148 109 7 249
Fabiana Cacace 108 4 138 80 10 199
Viviani Pessôa 111 6 212 127 8 295
Karen K. Swisher 120 59 191 123 9 277
Nobuaki Takagi 121 4 218 189 9 286
A Feroz 49 90 56 78 7 253
John O’Regan 35 38 125 168 9 284
D. Ponard 96 6 143 83 12 259

All Works

Loading papers...

Rankless by CCL
2026